Brexpiprazole in the Treatment of Major Depressive Disorder

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of Brexpiprazole as Adjunctive Treatment in Major Depressive Disorder With Irritability

To the Editors: I rritability in patients with major depressive disorder (MDD) has been associated with greater overall severity, previous suicide attempts, and suicidal ideations. Irritability in MDD is also associated with longer duration of episodes, a more chronic course of illness, impaired functioning, and less favorable outcomes. Irritability is a symptom often addressed with the use of ...

متن کامل

Vortioxetine versus placebo for treatment of major depressive disorder

Introduction: Major depressive disorder is a common mental condition associated with substantial morbidity and economic burden. Approved by the FDA in September 2013 for treatment of episodes of major depressive disorder, Vortioxetine is one of the newer options available in this important area of therapeutics. Materials and methods: A comprehensive literature search (PubMed, the Cochrane libr...

متن کامل

Comparing the Efficacy and Adverse Effects of Citalopram with Nortriptylinee in the Treatment of Major Depressive Disorder

Nazari H1, Saki M2, Sohrabi P3, Tarrahi MJ4, Movahedi M5, Badrizadeh A6, Baqeri Kh7 1. Assistant Professor, Department of Psychiatry, Faculty of Medicine, Lorestan University of Medical Sciences 2. Instructor, Department of Psychiatry, Faculty of Nursing and Midwifery, Lorestan University of Medical Sciences 3. General Practitioner, Neurology and Psychoiatry Hospital, Khorramabad 4....

متن کامل

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study

BACKGROUND Major depressive disorder (MDD) with concurrent anxiety symptoms may signal a difficult-to-treat patient. Brexpiprazole is a serotonin-dopamine activity modulator: a partial agonist at 5-HT1A and dopamine D2 receptors at similar potency, and an antagonist at 5-HT2A and noradrenaline alpha1B/2C receptors. The objective of this Phase IIIb study was to explore effectiveness, safety, and...

متن کامل

Sheehan’s Syndrome Presenting as Major Depressive Disorder

Sheehan’s syndrome or Simmond’s disease is a rare endocrine disorder seen in clinical practice. The clinical spectrum is diverse and a high index of suspicion together with a good clinical acumen and proper diagnostic approach helps in early diagnosis and prompt treatment of this endocrinopathy. Sheehan’s syndrome presenting as a major depressive disorder finds less mention in the literature.Th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Clinical Medicine Insights: Therapeutics

سال: 2017

ISSN: 1179-559X,1179-559X

DOI: 10.1177/1179559x17731801